NCT01569724View on ClinicalTrials.gov

Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
HypertriglyceridemiaCutaneous T Cell Lymphoma
Interventions
OTHER

oral glucose tolerance test (OGTT)

patients presenting an hypertriglyceridemia will have a oral glucose tolerance test (OGTT) in order to diagnose a carbohydrate metabolism disorder

Trial Locations (1)

35033

Service de dermatologie - Hôpital de Pontchaillou, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT01569724 - Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma | Biotech Hunter | Biotech Hunter